CN112898200A - Synthesis method of 5-bromo-6-methoxypyridine-2-carboxylic ester - Google Patents

Synthesis method of 5-bromo-6-methoxypyridine-2-carboxylic ester Download PDF

Info

Publication number
CN112898200A
CN112898200A CN202110074298.0A CN202110074298A CN112898200A CN 112898200 A CN112898200 A CN 112898200A CN 202110074298 A CN202110074298 A CN 202110074298A CN 112898200 A CN112898200 A CN 112898200A
Authority
CN
China
Prior art keywords
bromo
methoxypyridine
compound
mixture
carboxylate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110074298.0A
Other languages
Chinese (zh)
Inventor
王雷
许智
于海波
周伟赣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Du Chuang Shanghai Medical Technology Co ltd
Original Assignee
Du Chuang Shanghai Medical Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Chuang Shanghai Medical Technology Co ltd filed Critical Du Chuang Shanghai Medical Technology Co ltd
Priority to CN202110074298.0A priority Critical patent/CN112898200A/en
Publication of CN112898200A publication Critical patent/CN112898200A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6

Abstract

The invention discloses a synthesis method of 5-bromo-6-methoxypyridine-2-carboxylate, which develops two methods for synthesizing 5-bromo-6-methoxypyridine-2-carboxylate by taking 3-bromo-2-chloro-6-methylpyridine as a raw material, wherein the two methods are respectively a method for attacking carbonate by withdrawing hydrogen after substitution or a method for attacking carbonate by withdrawing hydrogen before substitution, and a target product 5-bromo-6-methoxypyridine-2-carboxylate is obtained only by two-step reaction. The synthetic method of the 5-bromo-6-methoxypyridine-2-carboxylic ester has the advantages of convenient and rapid reaction route, economy, environmental protection and huge potential economic value.

Description

Synthesis method of 5-bromo-6-methoxypyridine-2-carboxylic ester
Technical Field
The invention belongs to the technical field of organic synthesis, and particularly relates to a synthesis method of 5-bromo-6-methoxypyridine-2-carboxylic ester.
Background
The nitrogen-containing heterocycle is commonly found in natural products such as nucleoside, amino acid, sugar, vitamin, alkaloid and the like, and the heterocycle structure is introduced into a medicine molecule, so that the nitrogen-containing heterocycle has great effects on improving the selectivity and the utilization rate of the medicine, fat solubility and water solubility and molecular polarity, and belongs to good heart of medicinal chemists. From 2015, FDA approved small molecule drugs contain a large proportion of nitrogen heterocyclic molecules, pyridine ranks three in all nitrogen heterocyclic rings, so that the derivative of pyridine fragment compounds is of great significance for small molecule drug design, and 5-bromo-6-methoxypyridine-2-methyl acetate is a product of which the pyridine ring contains a halogen atom, and can be connected with a new fragment through coupling reaction such as Suzuki, Ullman and the like, and methyl ester can be subjected to more derivatization through amine ester exchange or amidation after hydrolysis, so that 5-bromo-6-methoxypyridine-2-methyl acetate (cas: 1206777-11-8) is a very practical drug intermediate.
Figure BDA0002907019200000011
Disclosure of Invention
The invention provides a synthesis method of 5-bromo-6-methoxypyridine-2-carboxylic ester, aiming at overcoming the defects in the prior art.
The invention is realized by the following technical scheme: the invention discloses a synthesis method of 5-bromo-6-methoxypyridine-2-carboxylate, which develops two methods for synthesizing 5-bromo-6-methoxypyridine-2-carboxylate by taking 3-bromo-2-chloro-6-methylpyridine as a raw material, wherein the two methods are respectively a method for attacking carbonate by withdrawing hydrogen after substitution or a method for attacking carbonate by withdrawing hydrogen before substitution, and a target product 5-bromo-6-methoxypyridine-2-carboxylate is obtained only by two-step reaction; the synthetic route is as follows:
Figure BDA0002907019200000021
r1, R2 include C1-C6 fatty carbon chains.
The invention relates to a synthesis method of 5-bromo-6-methoxypyridine-2-carboxylic ester, which comprises the following steps:
step 1:
adding 10g of compound 1 into a 250mL round-bottom flask, wherein the compound 1 is 3-bromo-2-chloro-6-methylpyridine, pouring 100mL of methanol to dissolve the compound 1 into a clear solution, then adding 10.5g of sodium methoxide with 4.0 equivalents, stirring the mixture at the temperature of 40-65 ℃ for 16 hours, after the reaction is finished, concentrating the mixture under reduced pressure to remove most of the methanol, adding 100mL of water into the rest reaction solution to quench the reaction solution, extracting the reaction solution for 3 times by using 100mL of ethyl acetate, combining organic phases, concentrating and drying the mixture to obtain 8.4g of white solid compound 2, wherein the yield is 80.6%;
step 2:
adding 0.4g of compound 2 and 0.09g of compound 4 in an amount of 5.0 equivalents into a 100mL round-bottom flask, pouring 20mL of tetrahydrofuran to dissolve the compound 4 into a clear solution, dropwise adding 1mL of LDA in an amount of 1.0 equivalent under a dry ice acetone bath, and stirring at room temperature for 2 hours after dropwise adding; adding 40mL of water into the reaction solution, quenching, extracting for 3 times by using 60mL of ethyl acetate, combining organic phases, concentrating, drying and carrying out column chromatography to obtain 0.28g of yellow solid 5-bromo-6-methoxypyridine-2-methyl acetate with the yield of 55%.
The invention discloses another synthesis method of 5-bromo-6-methoxypyridine-2-carboxylic ester, which comprises the following steps:
step 1:
adding 6.7g of compound 1 and 5.0 equivalents of compound 4 into a 500mL round-bottom flask, adding 3-bromo-2-chloro-6-methylpyridine as compound 1 and methyl carbonate as compound 4 into 150mL tetrahydrofuran, dissolving into a clear solution, adding 3.0 equivalents of lithium hexamethylsilazide, stirring at room temperature for 2 hours, adding 500mL of saturated NH4Cl solution into a reaction solution after the reaction is finished, quenching, extracting with 100mL of ethyl acetate for 3 times, drying, and concentrating to obtain 8.2g of yellow solid compound 5 with the yield of 95.5%;
step 2:
adding 8.0g of compound 5 into a 500mL round-bottom flask, pouring 100mL of methanol to dissolve the compound 5 into a clear solution, then adding 3.0 equivalents of sodium methoxide, stirring the mixture at the temperature of 40-65 ℃ for 16 hours, adding 200mL of saturated ammonium chloride solution into the reaction solution after the reaction is finished, quenching the mixture, extracting the mixture for 3 times by using 100mL of ethyl acetate, drying the mixture, concentrating the mixture, and performing column chromatography separation to obtain 2.9g of yellow solid 5-bromo-6-methoxypyridine-2-methyl acetate with the yield of 37.2%.
The concentration of the LDA is 2.0 mol/L.
The eluent for column chromatography separation is petroleum ether/ethyl acetate 10/1.
The invention has the beneficial effects that: the invention develops two novel methods for synthesizing 5-bromo-6-methoxypyridine-2-carboxylic ester by taking 3-bromo-2-chloro-6-methylpyridine as a raw material, and the method comprises the steps of replacing firstly and then drawing out hydrogen to attack carbonate or drawing out hydrogen to attack carbonate and then replacing, so that the target product 5-bromo-6-methoxypyridine-2-carboxylic ester is obtained through two-step reaction.
Detailed Description
The present invention will be described in detail with reference to specific examples.
Example 1: the invention relates to a synthesis method of 5-bromo-6-methoxypyridine-2-carboxylic ester, which comprises the following steps:
step 1: adding 10g of compound 1 into a 250mL round-bottom flask, wherein the compound 1 is 3-bromo-2-chloro-6-methylpyridine, pouring 100mL of methanol to dissolve the compound 1 into a clear solution, then adding 10.5g of sodium methoxide with 4.0 equivalents, stirring the mixture at the temperature of 40-65 ℃ for 16 hours, after the reaction is finished, concentrating the mixture under reduced pressure to remove most of the methanol, adding 100mL of water into the rest reaction solution to quench the reaction solution, extracting the reaction solution for 3 times by using 100mL of ethyl acetate, combining organic phases, concentrating and drying the mixture to obtain 8.4g of white solid compound 2, wherein the yield is 80.6%;
step 2: adding 0.4g of compound 2 and 0.09g of compound 4 in an amount of 5.0 equivalents into a 100mL round-bottom flask, pouring 20mL of tetrahydrofuran to dissolve the compound 4 into a clear solution, dropwise adding 1mL of LDA in an amount of 1.0 equivalent under a dry ice acetone bath, and stirring at room temperature for 2 hours after dropwise adding; adding 40mL of water into the reaction solution, quenching, extracting for 3 times by using 60mL of ethyl acetate, combining organic phases, concentrating, drying and carrying out column chromatography to obtain 0.28g of yellow solid 5-bromo-6-methoxypyridine-2-methyl acetate with the yield of 55%.
The synthetic route of example 1 is:
Figure BDA0002907019200000041
example 2: the invention discloses another synthesis method of 5-bromo-6-methoxypyridine-2-carboxylic ester, which comprises the following steps:
step 1: adding 6.7g of compound 1 and 5.0 equivalents of compound 4 into a 500mL round-bottom flask, adding 3-bromo-2-chloro-6-methylpyridine as compound 1 and methyl carbonate as compound 4 into 150mL tetrahydrofuran, dissolving into a clear solution, adding 3.0 equivalents of lithium hexamethylsilazide, stirring at room temperature for 2 hours, adding 500mL of saturated NH4Cl solution into a reaction solution after the reaction is finished, quenching, extracting with 100mL of ethyl acetate for 3 times, drying, and concentrating to obtain 8.2g of yellow solid compound 5 with the yield of 95.5%;
step 2: adding 8.0g of compound 5 into a 500mL round-bottom flask, pouring 100mL of methanol to dissolve the compound 5 into a clear solution, then adding 3.0 equivalents of sodium methoxide, stirring the mixture at the temperature of 40-65 ℃ for 16 hours, adding 200mL of saturated ammonium chloride solution into the reaction solution after the reaction is finished, quenching the mixture, extracting the mixture for 3 times by using 100mL of ethyl acetate, drying the mixture, concentrating the mixture, and performing column chromatography separation to obtain 2.9g of yellow solid 5-bromo-6-methoxypyridine-2-methyl acetate with the yield of 37.2%.
The synthetic route of example 2 is:
Figure BDA0002907019200000051
finally, it should be noted that the above-mentioned contents are only used for illustrating the technical solutions of the present invention, and not for limiting the protection scope of the present invention, and that the simple modifications or equivalent substitutions of the technical solutions of the present invention by those of ordinary skill in the art can be made without departing from the spirit and scope of the technical solutions of the present invention.

Claims (5)

1. A synthetic method of 5-bromo-6-methoxypyridine-2-carboxylate is characterized by comprising the following steps: the synthesis method of the 5-bromo-6-methoxypyridine-2-carboxylate is characterized in that two methods for synthesizing the 5-bromo-6-methoxypyridine-2-carboxylate are developed by taking 3-bromo-2-chloro-6-methylpyridine as a raw material, wherein the two methods are respectively a method for attacking carbonate by hydrogen after substitution or a method for attacking carbonate by hydrogen before substitution, and the target product 5-bromo-6-methoxypyridine-2-carboxylate is obtained by only two-step reaction; the synthetic route is as follows:
Figure FDA0002907019190000011
r1, R2 include C1-C6 fatty carbon chains.
2. The method of synthesizing 5-bromo-6-methoxypyridine-2-carboxylate according to claim 1, wherein: the synthesis method of the 5-bromo-6-methoxypyridine-2-carboxylic ester specifically comprises the following steps:
step 1:
adding 10g of compound 1 into a 250mL round-bottom flask, wherein the compound 1 is 3-bromo-2-chloro-6-methylpyridine, pouring 100mL of methanol to dissolve the compound 1 into a clear solution, then adding 10.5g of sodium methoxide with 4.0 equivalents, stirring the mixture at the temperature of 40-65 ℃ for 16 hours, after the reaction is finished, concentrating the mixture under reduced pressure to remove most of the methanol, adding 100mL of water into the rest reaction solution to quench the reaction solution, extracting the reaction solution for 3 times by using 100mL of ethyl acetate, combining organic phases, concentrating and drying the mixture to obtain 8.4g of white solid compound 2, wherein the yield is 80.6%;
step 2:
adding 0.4g of compound 2 and 0.09g of compound 4 in an amount of 5.0 equivalents into a 100mL round-bottom flask, pouring 20mL of tetrahydrofuran to dissolve the compound 4 into a clear solution, dropwise adding 1mL of LDA in an amount of 1.0 equivalent under a dry ice acetone bath, and stirring at room temperature for 2 hours after dropwise adding; adding 40mL of water into the reaction solution, quenching, extracting for 3 times by using 60mL of ethyl acetate, combining organic phases, concentrating, drying and carrying out column chromatography to obtain 0.28g of yellow solid 5-bromo-6-methoxypyridine-2-methyl acetate with the yield of 55%.
3. The method of synthesizing 5-bromo-6-methoxypyridine-2-carboxylate according to claim 1, wherein: the synthesis method of the 5-bromo-6-methoxypyridine-2-carboxylic ester specifically comprises the following steps:
step 1:
adding 6.7g of compound 1 and 5.0 equivalents of compound 4 into a 500mL round-bottom flask, adding 3-bromo-2-chloro-6-methylpyridine as compound 1 and methyl carbonate as compound 4 into 150mL tetrahydrofuran, dissolving into a clear solution, adding 3.0 equivalents of lithium hexamethylsilazide, stirring at room temperature for 2 hours, adding 500mL of saturated NH4Cl solution into a reaction solution after the reaction is finished, quenching, extracting with 100mL of ethyl acetate for 3 times, drying, and concentrating to obtain 8.2g of yellow solid compound 5 with the yield of 95.5%;
step 2:
adding 8.0g of compound 5 into a 500mL round-bottom flask, pouring 100mL of methanol to dissolve the compound 5 into a clear solution, then adding 3.0 equivalents of sodium methoxide, stirring the mixture at the temperature of 40-65 ℃ for 16 hours, adding 200mL of saturated ammonium chloride solution into the reaction solution after the reaction is finished, quenching the mixture, extracting the mixture for 3 times by using 100mL of ethyl acetate, drying the mixture, concentrating the mixture, and performing column chromatography separation to obtain 2.9g of yellow solid 5-bromo-6-methoxypyridine-2-methyl acetate with the yield of 37.2%.
4. The method of synthesizing 5-bromo-6-methoxypyridine-2-carboxylate according to claim 2, wherein: the concentration of the LDA is 2.0 mol/L.
5. The method of synthesizing 5-bromo-6-methoxypyridine-2-carboxylate according to claim 3, wherein: the eluent for column chromatography separation is petroleum ether/ethyl acetate 10/1.
CN202110074298.0A 2021-01-20 2021-01-20 Synthesis method of 5-bromo-6-methoxypyridine-2-carboxylic ester Pending CN112898200A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110074298.0A CN112898200A (en) 2021-01-20 2021-01-20 Synthesis method of 5-bromo-6-methoxypyridine-2-carboxylic ester

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110074298.0A CN112898200A (en) 2021-01-20 2021-01-20 Synthesis method of 5-bromo-6-methoxypyridine-2-carboxylic ester

Publications (1)

Publication Number Publication Date
CN112898200A true CN112898200A (en) 2021-06-04

Family

ID=76116482

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110074298.0A Pending CN112898200A (en) 2021-01-20 2021-01-20 Synthesis method of 5-bromo-6-methoxypyridine-2-carboxylic ester

Country Status (1)

Country Link
CN (1) CN112898200A (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102099335A (en) * 2008-07-23 2011-06-15 弗·哈夫曼-拉罗切有限公司 Heterocyclic antiviral compounds
US20120202787A1 (en) * 2009-10-20 2012-08-09 Pfizer Inc. Novel Heteroaryl Imidazoles And Heteroaryl Triazoles As Gamma-Secretase Modulators
US20140371269A1 (en) * 2012-01-23 2014-12-18 Eli Lilly And Company Phenyl methanesulfonamide derivatives useful as mgat-2 inhibitors
CN104321325A (en) * 2012-05-24 2015-01-28 诺华股份有限公司 Pyrrolopyrrolidinone compounds
CN104936954A (en) * 2012-11-22 2015-09-23 安吉奥斯医药品有限公司 Compounds and their methods of use
US20170050980A1 (en) * 2015-08-18 2017-02-23 Forum Pharmaceuticals Inc. Oxadiazine compounds and methods of use thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102099335A (en) * 2008-07-23 2011-06-15 弗·哈夫曼-拉罗切有限公司 Heterocyclic antiviral compounds
US20120202787A1 (en) * 2009-10-20 2012-08-09 Pfizer Inc. Novel Heteroaryl Imidazoles And Heteroaryl Triazoles As Gamma-Secretase Modulators
US20140371269A1 (en) * 2012-01-23 2014-12-18 Eli Lilly And Company Phenyl methanesulfonamide derivatives useful as mgat-2 inhibitors
CN104321325A (en) * 2012-05-24 2015-01-28 诺华股份有限公司 Pyrrolopyrrolidinone compounds
CN104936954A (en) * 2012-11-22 2015-09-23 安吉奥斯医药品有限公司 Compounds and their methods of use
US20170050980A1 (en) * 2015-08-18 2017-02-23 Forum Pharmaceuticals Inc. Oxadiazine compounds and methods of use thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
VIKTOR BARAT ET AL.: ""Synthesis of (−)-Cytisine Using a 6-endo aza-Michael Addition"", 《THE JOURNAL OF ORGANIC CHEMISTRY》 *

Similar Documents

Publication Publication Date Title
WO2017096996A1 (en) Preparation method for cobimetinib
CN107011321A (en) A kind of preparation method of artificial synthesized raceme nicotine
CN104910002B (en) A kind of preparation method of dezocine key intermediate
CN110183367A (en) A kind of synthetic method of (3R, 4S) -1- benzyloxycarbonyl group -4- N-ethyl pyrrole N -3- carboxylic acid suitable for industrialization
CN111171027B (en) Preparation method of (R) -praziquantel
CN112898200A (en) Synthesis method of 5-bromo-6-methoxypyridine-2-carboxylic ester
CN110294748B (en) Synthesis method of teneligliptin key intermediate
CN104016867A (en) Synthesis method of 1-nitro-3,4:9,10-perylene tetracarboxylate and 1,6(7)-binitro-3,4:9,10-perylene tetracarboxylate
CN109369611B (en) Synthetic method of 4-chlorothiophene-2-carbonyl derivative
CN104771392B (en) Class I histone deacetylase inhibitor and application
CN104478974B (en) A kind of 20, the synthetic method of 23-dipiperidino-5-O-mycamino syl-tylono lide
CN114014773A (en) Preparation method of N-acetyl-L-aspartic acid
CN110803994B (en) Synthetic method of pregabalin intermediate 3-nitromethylene-5-methyl-ethyl caproate
CN106349145A (en) Method for preparing intelligence-improving medicine (S)-oxiracetam
CN105646284A (en) Lacosamide synthesis method
CN110804022A (en) Preparation method of dexrazoxane
CN105130972A (en) Emtricitabine benzoate, preparation method thereof, and method of preparing emtricitabine from emtricitabine benzoate
CN109280049B (en) Synthetic method of medical compound avanafil
CN112457235B (en) Preparation method of 7-methylindole
CN112876409A (en) Synthesis method of 2- (5-bromo-6-methoxypyridine-2-yl) acetonitrile and derivatives thereof
CN112759575B (en) Preparation method of clopidogrel hydrogen sulfate and intermediate N- (2-thienylethyl) methylamine thereof
CN115677456B (en) Preparation method of cannabidiol
WO2014106419A1 (en) Process for synthesizing 1-methyl-2-oxo-3,6,7-trioxabicyclo[2,2,2]octane
CN111087433B (en) Preparation method of tulathromycin intermediate
CN112661727B (en) Purification method of 7- (2, 2-trichloroethyl oxycarbonyl) taxol

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20210604